Results 81 to 90 of about 5,511 (190)

Effect of Sevelamer on Mineral and Lipid Abnormalities in Hemodialysis Patients

Saudi Journal of Kidney Diseases and Transplantation, 2008
We conducted a prospective study in hemodialysis patients to assess the safety and efficacy of sevelamer, a non-absorbable phosphate binding polymer free of calcium and aluminum, in lowering serum phosphorus, serum intact parathyroid hormone, and serum ...
Hamida Fethi, Fatma Lilia, Barbouch Samia, Kaaroud Hayet, Helal Imed, Hedri Hafedh, Abdallah Taieb, Maiz Hedi, Kheder Adel   +8 more
doaj  

Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis [PDF]

, 2019
Background: Etelcalcetide is an intravenous calcimimetic approved for treatment of secondary hyperparathyroidism (sHPT) in patients receiving hemodialysis. Besides lowering parathyroid hormone (PTH), etelcalcetide also significantly reduces fibroblast
Block, Geoffrey A., Chertow, Glenn M., Cooper, Kerry, Fouqueray, Bruno, Moe, Sharon M., Oberbauer, Rainer, Sun, Yan, Tomlin, Holly, Vervloet, Marc, Wolf, Myles   +9 more
core   +1 more source

Uremic Pericarditis in a Patient With Hyperphosphatemic Familial Tumoral Calcinosis: Case Report

Case Reports in Medicine, Volume 2025, Issue 1, 2025.
Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare hereditary disorder characterized by defective phosphate homeostasis, leading to ectopic calcium deposition in soft tissues. This case report describes a 41 year‐old Jordanian male with HFTC and stage 5 chronic kidney disease (CKD) secondary to nonsteroidal anti‐inflammatory drug (NSAID ...
Rana A. Nabalawi, Poulami Jha
wiley   +1 more source

Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial

BMC Nephrology, 2012
Background Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that is secreted from bone and serum level increases as renal function declines.
Bleskestad Inger H, Bergrem Harald, Hartmann Anders, Godang Kristin, Gøransson Lasse G   +4 more
doaj   +1 more source

Brazilian Registry of Bone Biopsy (REBRABO): design, data elements and methodology [PDF]

, 2014
Introduction: Mineral bone disorder (MBD) is a common condition in chronic kidney disease (CKD) patients and causes significant morbidity and mortality.
Barreto, Fellype Carvalho, Canziani, Maria Eugênia Fernandes, Carvalho, Aluizio Barbosa de, Costa, Rackel Mota da, Custódio, Melani Ribeiro, Gueiros, José Edvanilson Barros, Jorgetti, Vanda, Karohl, Cristina, Moysés, Rosa Maria Afonso, Neves, Carolina Lara, Oliveira, Rodrigo Bueno de, Sampaio, Elisa de Albuquerque   +11 more
core   +2 more sources

The impact of sevelamer in aluminum phosphide poisoning: a preliminary study on mortality

Medicina Clínica Práctica
Background: Aluminum phosphide (ALP) poisoning, commonly referred to as rice tablet poisoning, is among the deadliest forms of poisoning. Treatment for aluminum phosphide poisoning is limited to supportive care, as no specific antidote is currently ...
Kiandokht Khorshidi, Maral Ramezani, Mitra Rahimi, Shahin Shadnia, Babak Mostafazadeh, Peyman Erfan Talab Evini   +5 more
doaj   +1 more source

Use of phosphate binders in end-stage renal disease: An experience from a secondary care hospital in United Arab Emirates

Journal of Pharmacy and Bioallied Sciences, 2019
Objective: Hyperphosphatemia in end-stage renal disease (ESRD) is associated with many serious patient-level consequences including cardiovascular events and mortality.
Syed Arman Rabbani, Sathvik B Sridhar, Padma G M Rao, Martin T Kurian, Basset E Essawy   +4 more
doaj   +1 more source

The effect of intravenous vitamin C on the phosphorus level reduction in hemodialysis patients: A double blind randomized clinical trial [PDF]

, 2012
Aim The majority of hemodialysis patients are hyperphosphate-mic. Hyperphosphatemia in these patients can lead to renal oste-odystrophy, vascular calcifcation, cardiovascular events, and is independently associated with mortality risk.
Aarabi, M., Baradari, A.G., Espahbodi, F., Zeydi, A.E.   +3 more
core  

The Italian Multicentric Study on the Prevalence of Vascular Calcifications and Vertebral Fractures in parathyroidectomised (PTX) Dialysis Patients (Cave PTX Study): Phase I Results [PDF]

, 2014
Lo studio CAVE PTX ha lo scopo di valutare la reale prevalenza della paratiroidectomia nei pazienti dializzati in Italia, verificare l’aderenza ai targets ematochimici proposti dalle linee guida internazionali K/DOQI e ricercare la presenza di fratture ...
Conte, Carmina <1975>
core   +1 more source

Calcinosis cutis of the lower legs – hyperphosphatemic familial tumoral calcinosis in a patient with GALNT3 mutation

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 9, Page 1144-1146, September 2025.
David Ranzinger, Tobias Schaefer, Franziska Schauer, Kilian Eyerich, Anna Caroline Pilz   +4 more
wiley   +1 more source